top of page

Meet NewBiologix, an innovative Swiss biotech company dedicated to revolutionizing the field of gene therapy

  • blonca9
  • May 16
  • 1 min read

At #ASGCT2025, we met up with Founder and CEO Igor Fisch, who described the pillars that make NewBiologix a partner of choice in the rAAV field.



Key pillars:


I. Its proprietary Xcell™ Eng-HEK293 Cell Line.

II. Production of rAAV samples that are of the highest purity and quality.

III. Analytics that ensure clients receive the highest quality data and insights.


He also describes how NewBiologix will offer a new platform that allows for the production of viral particles with a stable cell line so that triple transfection isn't needed, thus lowering the cost of goods significantly.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page